Coronary Artery Bypass Grafting (CABG) Market Research Report, Analysis and Forecast – (2021 – 2027)

Rising Global Prevalence of Cardiovascular Diseases Driving the Coronary Artery Bypass Grafting (CABG) Market 

The Coronary Artery Bypass Grafting (CABG) Market is experiencing a sharp rise in demand, primarily propelled by the increasing global prevalence of cardiovascular diseases. For instance, coronary artery disease remains the leading cause of death globally, contributing to over 9 million deaths annually. The growing elderly population, coupled with sedentary lifestyles, has fueled a surge in cardiovascular complications. As a result, hospitals and cardiac centers are witnessing a notable rise in surgical interventions such as CABG. Datavagyanik states that the global burden of ischemic heart disease is escalating, and CABG procedures have become a cornerstone in the long-term management of multi-vessel coronary disease, driving robust market growth. 

Technological Advancements in Surgical Techniques Strengthening the Coronary Artery Bypass Grafting (CABG) Market 

Minimally invasive surgical technologies are significantly transforming the landscape of the Coronary Artery Bypass Grafting (CABG) Market. For example, the shift from conventional open-heart procedures to off-pump and robot-assisted CABG has reduced recovery times, hospital stays, and post-operative complications. According to Datavagyanik, the adoption of advanced imaging systems and intraoperative monitoring tools is enabling higher precision and better surgical outcomes. This evolution in surgical capability is encouraging both patients and healthcare providers to prefer CABG procedures over pharmacological interventions, directly boosting market adoption. 

Surge in Healthcare Infrastructure Investments Amplifying the Coronary Artery Bypass Grafting (CABG) Market 

A growing wave of investment in cardiac care infrastructure is playing a pivotal role in the development of the Coronary Artery Bypass Grafting (CABG) Market. For instance, governments across developing nations are allocating larger portions of their healthcare budgets toward the establishment of specialized cardiac centers and operating theaters. Datavagyanik highlights that countries such as India and Brazil have recorded a 15% to 20% annual increase in the number of public and private hospitals offering CABG surgeries. The accessibility of trained cardiac surgeons and enhanced diagnostic capabilities in these regions is also catalyzing procedural volumes. 

Rising Preference for Long-Term Solutions Boosting the Coronary Artery Bypass Grafting (CABG) Market 

Patients and clinicians are increasingly gravitating toward long-term solutions for coronary artery disease, reinforcing the demand within the Coronary Artery Bypass Grafting (CABG) Market. For example, while angioplasty and stenting offer short-term relief, CABG provides sustained benefits for patients with complex or multi-vessel disease. Datavagyanik emphasizes that CABG offers higher survival rates and reduced rates of repeat revascularization. A study showed that patients undergoing CABG had a 20% lower chance of future cardiac events compared to those who received stents. This preference for longevity and effectiveness is stimulating consistent market expansion. 

Increasing Burden of Diabetes and Hypertension Fuels the Coronary Artery Bypass Grafting (CABG) Market 

The rising incidence of comorbid conditions such as diabetes and hypertension is directly influencing the growth trajectory of the Coronary Artery Bypass Grafting (CABG) Market. For example, individuals with type 2 diabetes are two to four times more likely to develop coronary artery disease. Datavagyanik indicates that over 40% of CABG patients present with diabetes, making them high-priority candidates for surgical interventions. With more than 530 million people globally living with diabetes, and numbers expected to rise to 640 million by 2030, the addressable patient pool for CABG continues to expand rapidly. 

Growing Adoption of Hybrid Revascularization Approaches Enhancing the Coronary Artery Bypass Grafting (CABG) Market 

Hybrid coronary revascularization (HCR), which combines surgical grafting with percutaneous coronary intervention (PCI), is gaining momentum and redefining the Coronary Artery Bypass Grafting (CABG) Market. For instance, hybrid approaches allow surgeons to use minimally invasive techniques for the left internal mammary artery graft while using PCI for other vessels. Datavagyanik notes that hybrid models reduce operative trauma while maintaining the long-term benefits of surgical grafts. The rising acceptance of HCR procedures in high-volume cardiac centers is creating a diversified revenue stream within the CABG ecosystem. 

Expansion in Medical Tourism Supporting the Coronary Artery Bypass Grafting (CABG) Market 

The emergence of medical tourism is further contributing to the development of the Coronary Artery Bypass Grafting (CABG) Market. Countries such as Thailand, India, and Turkey have become prominent destinations for affordable yet high-quality CABG procedures. For example, the cost of CABG in India is nearly 70% lower than in Western countries, without compromising clinical outcomes. Datavagyanik observes that international patient inflows to these countries have grown by 10% to 12% annually over the past five years, helping regional players in Asia-Pacific gain a stronger foothold in the global market. 

Coronary Artery Bypass Grafting (CABG) Market Size Expanding Due to High Procedure Volumes 

As CABG becomes a routine and preferred surgical intervention for severe coronary artery blockages, the Coronary Artery Bypass Grafting (CABG) Market Size is expanding at an accelerated pace. For instance, the global procedural volume crossed over 1 million CABG surgeries in 2023, reflecting a steady compound annual growth rate (CAGR) of over 6%. Datavagyanik projects that this number will reach 1.3 million procedures annually by 2028. The consistent rise in procedure count is directly contributing to the widening scope and financial value of the market. 

Aging Population a Major Contributor to the Coronary Artery Bypass Grafting (CABG) Market 

The demographic shift toward an aging global population is a significant factor propelling the Coronary Artery Bypass Grafting (CABG) Market. Individuals aged 65 and older are disproportionately affected by cardiovascular issues due to cumulative vascular damage and coexisting comorbidities. For example, Datavagyanik highlights that over 65% of CABG procedures are conducted in this age group. With global life expectancy rising and elderly populations growing in both developed and developing economies, the demand for CABG procedures is expected to remain robust and climb steadily. 

Shortcomings of Drug-Based Therapies Pushing Demand in the Coronary Artery Bypass Grafting (CABG) Market 

Limitations associated with drug-based management of coronary artery disease are prompting a shift toward surgical alternatives, thereby expanding the Coronary Artery Bypass Grafting (CABG) Market. For example, medications such as beta-blockers and statins manage symptoms but fail to restore full blood flow or reverse severe occlusions. Datavagyanik identifies a growing trend among cardiologists who recommend early surgical intervention for high-risk patients, especially those with triple-vessel disease or left main coronary artery involvement. The declining efficacy of medical therapy in complex cases underscores the growing clinical reliance on CABG. 

Coronary Artery Bypass Grafting (CABG) Market Size Supported by Device and Consumables Growth 

The ecosystem surrounding CABG procedures, including surgical devices, graft materials, and perfusion systems, is growing in tandem, supporting the expansion of the Coronary Artery Bypass Grafting (CABG) Market Size. For instance, the demand for synthetic and biological grafts, such as ePTFE and Dacron, is witnessing a CAGR of over 7%. Datavagyanik notes that the rise in customized surgical kits and cardiopulmonary bypass systems has also led to improved operational efficiency and surgical success rates. This ecosystem-based growth ensures the market is not solely reliant on procedural volumes but also on recurring device sales. 

 

“Track Country-wise Catheters Production and Demand through our Database”

• • • Catheters sales volume database for 28+ countries worldwide

North America Maintains Dominance in the Coronary Artery Bypass Grafting (CABG) Market 

North America remains the largest contributor to the Coronary Artery Bypass Grafting (CABG) Market, driven by high healthcare expenditure, advanced surgical infrastructure, and a significant elderly population. For instance, the United States performs over 200,000 CABG surgeries annually, supported by a robust network of specialized cardiovascular centers and continuous advancements in surgical technologies. Datavagyanik highlights that nearly 40% of all CABG procedures globally are performed in North America, largely due to strong insurance coverage and awareness programs around heart health. Furthermore, the region’s rising incidence of obesity and type 2 diabetes continues to generate high Coronary Artery Bypass Grafting (CABG) demand. 

Europe Witnesses Steady Growth in the Coronary Artery Bypass Grafting (CABG) Market 

The Coronary Artery Bypass Grafting (CABG) Market in Europe is displaying consistent momentum, led by countries such as Germany, the UK, and France. For example, Germany alone performs over 50,000 CABG procedures annually, owing to its aging population and government-backed universal healthcare model. Datavagyanik notes that the region is showing a rising preference for minimally invasive CABG techniques, particularly in urban hospital settings. European initiatives promoting preventive cardiology are also indirectly boosting Coronary Artery Bypass Grafting (CABG) demand, especially among high-risk demographic segments aged over 60. 

Asia-Pacific Emerges as a Fast-Growing Region in the Coronary Artery Bypass Grafting (CABG) Market 

Asia-Pacific is the fastest-expanding regional cluster in the Coronary Artery Bypass Grafting (CABG) Market, supported by a surging middle class, improving healthcare infrastructure, and increasing cardiovascular disease prevalence. For instance, India and China together contribute to nearly 25% of all global heart disease cases. Datavagyanik emphasizes that the affordability of procedures in India—where a full CABG surgery may cost one-tenth of its price in Western countries—is attracting both domestic and international patients. Additionally, with more than 700 cardiac centers being developed in Southeast Asia over the past five years, the Coronary Artery Bypass Grafting (CABG) demand in the region is expected to grow at a CAGR exceeding 9%. 

Middle East and Africa Expanding Slowly but Strategically in the Coronary Artery Bypass Grafting (CABG) Market 

While comparatively smaller, the Coronary Artery Bypass Grafting (CABG) Market in the Middle East and Africa is witnessing incremental growth due to rising healthcare investments and strategic partnerships with global cardiac institutions. For example, countries like the UAE and Saudi Arabia are establishing specialty cardiac centers to handle the growing prevalence of non-communicable diseases. Datavagyanik observes that public-private partnerships are increasing CABG procedure availability, while medical tourism is slowly becoming a supplementary growth engine in Gulf nations. However, access inequality across sub-Saharan Africa remains a limitation, restraining uniform growth across the entire region. 

Coronary Artery Bypass Grafting (CABG) Market Segmentation by Procedure Type 

Segmentation by procedure type within the Coronary Artery Bypass Grafting (CABG) Market reveals a growing preference for off-pump CABG procedures. For example, off-pump or “beating heart” surgery reduces the risk of stroke and neurological complications, especially in elderly patients. Datavagyanik notes that this segment accounts for nearly 35% of all global CABG surgeries and is growing at a pace of 7.5% annually. Conversely, on-pump CABG continues to dominate in highly complex, multi-vessel cases where precision is paramount. Hybrid procedures—combining CABG with stenting—are also gaining popularity, especially in high-tech hospital environments. 

Coronary Artery Bypass Grafting (CABG) Market Segmentation by End User 

Hospitals remain the primary end users in the Coronary Artery Bypass Grafting (CABG) Market, accounting for more than 80% of the procedural volume. For instance, tertiary care hospitals with cardiac ICUs are equipped to handle both emergency and elective CABG surgeries. Datavagyanik underscores that the number of hospitals equipped with advanced cardiothoracic facilities is growing at 6% annually in developing countries. Meanwhile, specialty cardiac centers and ambulatory surgery centers (ASCs) are emerging as secondary hubs, especially in urban clusters where healthcare delivery models are shifting toward outpatient and short-stay formats to reduce patient costs. 

Coronary Artery Bypass Grafting (CABG) Market Segmentation by Graft Type 

The choice of graft type significantly influences outcomes and cost structure within the Coronary Artery Bypass Grafting (CABG) Market. Autologous grafts, particularly the internal mammary artery and saphenous vein, continue to dominate due to their proven patency and lower rejection rates. For example, Datavagyanik reports that over 90% of CABG procedures still rely on autologous materials. However, synthetic grafts made from PTFE or Dacron are gaining adoption in cases where natural grafts are unsuitable. This growing sub-segment is expanding at a CAGR of 8.2%, driven by improvements in biomaterial engineering. 

Price Trends Reshaping the Coronary Artery Bypass Grafting (CABG) Market 

The Coronary Artery Bypass Grafting (CABG) Market is experiencing dynamic pricing trends based on geography, procedure type, and institutional capabilities. For example, the cost of a CABG surgery in the United States ranges from USD 70,000 to USD 120,000, depending on hospital infrastructure and insurance models. Meanwhile, in India, similar procedures can be accessed for USD 6,000 to USD 10,000, thanks to lower labor and operational costs. Datavagyanik points out that value-based pricing models are becoming prominent, where hospitals are incentivized based on patient outcomes rather than volume alone. This transition is expected to influence global CABG pricing models over the next five years. 

Coronary Artery Bypass Grafting (CABG) Demand Rising in Emerging Urban Clusters 

Secondary cities and semi-urban zones are witnessing a sharp increase in Coronary Artery Bypass Grafting (CABG) demand due to rising heart disease rates and increased awareness. For instance, cities like Pune, Bandung, and Lagos are developing cardiac care units with local surgeons being trained under international collaborations. Datavagyanik highlights that urbanization and lifestyle changes—such as fast food consumption, physical inactivity, and smoking—are directly correlated with higher CABG case loads in these cities. As healthcare providers expand into Tier-2 cities, the market’s reach is expected to grow beyond major metropolitan regions. 

Coronary Artery Bypass Grafting (CABG) Market Segmentation by Patient Profile 

Segmentation by patient profile reveals that the Coronary Artery Bypass Grafting (CABG) Market is heavily skewed toward male patients aged 55 and above, although younger demographics are increasingly presenting with complex coronary artery disease. For example, Datavagyanik notes a 15% rise in CABG procedures among patients aged 40–50, largely due to genetic predisposition and poor lifestyle choices. Women, while underrepresented in procedural statistics, are showing a rising trend, especially in developed nations where gender-specific cardiac awareness programs are gaining traction. 

Influence of Reimbursement and Policy Frameworks on the Coronary Artery Bypass Grafting (CABG) Market 

Reimbursement policies play a critical role in shaping the Coronary Artery Bypass Grafting (CABG) Market, particularly in the United States, Canada, and several parts of Europe. For instance, Datavagyanik observes that bundled payment models and quality-linked incentives are pushing hospitals to optimize surgical pathways and reduce complications. In emerging markets, public insurance programs are slowly beginning to cover CABG procedures, widening accessibility to lower-income populations. This policy-driven demand is expected to increase Coronary Artery Bypass Grafting (CABG) demand significantly, particularly in regions where out-of-pocket expenditure remains high. 

 

“Catheters Manufacturing Database”

• • • Catheters top manufacturers market share for 28+ manufacturers
    • Top 8 manufacturers and top 18 manufacturers of Catheters in North America, Europe, Asia Pacific
    • Catheters sales dashboard, Catheters sales data in excel format

 

Leading Players in the Coronary Artery Bypass Grafting (CABG) Market 

The Coronary Artery Bypass Grafting (CABG) Market is characterized by the presence of several key players who contribute significantly to its growth and innovation. These companies offer a range of products and services that cater to various aspects of CABG procedures. 

Medtronic is a prominent player in the Coronary Artery Bypass Grafting (CABG) Market, offering a comprehensive portfolio that includes heart-lung machines, cannulae, and surgical instruments essential for CABG procedures. Their commitment to innovation and quality has solidified their position in the market. 

Terumo Corporation has established itself as a key contributor to the Coronary Artery Bypass Grafting (CABG) Market through its advanced perfusion systems and oxygenators. Their products are widely used in on-pump CABG surgeries, ensuring patient safety and procedural efficiency. 

Getinge AB, through its Maquet brand, provides a range of products such as stabilizers and positioning devices that are integral to off-pump CABG procedures. Their focus on enhancing surgical outcomes has made them a trusted name in the market. 

Edwards Lifesciences offers specialized grafts and surgical tools that support complex CABG surgeries. Their products are designed to improve patient outcomes and reduce recovery times, contributing to the overall growth of the Coronary Artery Bypass Grafting (CABG) Market. 

Boston Scientific has expanded its presence in the Coronary Artery Bypass Grafting (CABG) Market by developing minimally invasive surgical tools and devices. Their innovations aim to reduce procedural risks and improve patient comfort. 

Abbott Laboratories provides a range of vascular grafts and surgical instruments that are essential for CABG procedures. Their commitment to research and development has led to the introduction of products that enhance surgical precision. 

LivaNova specializes in advanced perfusion systems and cannulation products that are critical for successful CABG surgeries. Their technologies are designed to optimize patient outcomes and streamline surgical processes. 

Stryker Corporation offers a variety of surgical instruments and devices that support CABG procedures. Their focus on ergonomic design and functionality has made their products popular among cardiac surgeons. 

Johnson & Johnson, through its Ethicon division, provides surgical sutures and wound closure devices that are vital for CABG surgeries. Their products are known for their reliability and effectiveness. 

Terumo Cardiovascular Systems Corporation offers a range of products including oxygenators and perfusion systems that are essential for on-pump CABG procedures. Their technologies are designed to ensure patient safety and procedural success. 

 

Market Share Distribution in the Coronary Artery Bypass Grafting (CABG) Market 

The Coronary Artery Bypass Grafting (CABG) Market is segmented among these key players, each holding a significant share based on their product offerings and geographical presence. 

• Medtronic holds a substantial share due to its extensive product portfolio and global reach. 

• Terumo Corporation commands a significant portion of the market, particularly in perfusion systems and oxygenators. 

• Getinge AB has a strong presence in the off-pump CABG segment, owing to its specialized surgical devices. 

• Edwards Lifesciences maintains a notable share through its innovative grafts and surgical tools. 

• Boston Scientific continues to grow its market share by focusing on minimally invasive surgical solutions. 

 

Recent Developments in the Coronary Artery Bypass Grafting (CABG) Market 

The Coronary Artery Bypass Grafting (CABG) Market has witnessed several notable developments that have influenced its trajectory: 

• In August 2024, DePuy Synthes launched the MatrixSTERNUM Fixation System, designed to stabilize the chest wall following open-heart surgeries, enhancing patient recovery. 

• In October 2023, SS Innovations International, Inc. introduced a robotic cardiac surgery program in India, featuring the SSi Mantra surgical robotic system, aiming to advance robotic CABG procedures. 

• In April 2024, the Society of Thoracic Surgeons (STS) introduced new risk calculators for various cardiac surgeries, including CABG, to improve surgical planning and patient outcomes. 

• In August 2022, Grand Pharmaceutical Group invested €15 million in Xeltis, focusing on developing polymer-based cardiovascular restorative devices, including those used in CABG surgeries. 

• In January 2022, Humacyte released results from a preclinical trial using its Human Acellular Vessel (HAV) in CABG procedures, indicating potential for improved graft performance. 

 

“Catheters Production Data and Catheters Production Trend”

• • • Catheters sales database for historical years, 10 years historical data
    • Catheters sales data and forecast for next 7 years